Clinical Trial: A Study to Assess NEU-627 in Healthy Participants

U.S., March 29 -- ClinicalTrials.gov registry received information related to the study (NCT06900751) titled 'A Study to Assess NEU-627 in Healthy Participants' on March 17.

Brief Summary: Phase 1, randomized, double-blind, placebo-controlled study of NEU-627 designed to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, and food effect.

Study Start Date: May, 2025

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: NEU-627

Investigational medicinal product

OTHER: Placebo

Placebo

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Neuron23 Inc.

Published by HT Digital Content Services with permission from Health Daily Digest....